FDA worried drug was risky; now reports of deaths spark concern

Doctors and other experts tell CNN they worried that a new drug, Nuplazid, aimed at treating Parkinson’s Disease patients with hallucinations was approved too quickly. Now hundreds of reports of deaths are raising more red flags.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>